| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681993 | Clinical Neurology and Neurosurgery | 2018 | 7 Pages |
Abstract
According to our experience, PIMM is very aggressive malignant tumor. Its median survival was less than 1Â year. We suggest that maximal safe resection plus adjuvant RT and CTX for intracranial malignant melanoma considering highly aggressive clinical course of this tumors.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Joonho Byun, Eun Suk Park, Seok Ho Hong, Young Hyun Cho, Young-Hoon Kim, Chang Jin Kim, Jeong Hoon Kim, Seungjoo Lee,